nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—Nafarelin—Goserelin—breast cancer	0.225	0.524	CrCrCtD
Desmopressin—Gonadorelin—Goserelin—breast cancer	0.205	0.476	CrCrCtD
Desmopressin—PTGS1—breast cancer	0.198	0.636	CbGaD
Desmopressin—PTGS2—breast cancer	0.113	0.364	CbGaD
Desmopressin—AVPR1A—adrenal gland—breast cancer	0.000865	0.144	CbGeAlD
Desmopressin—AVPR2—adipose tissue—breast cancer	0.000799	0.133	CbGeAlD
Desmopressin—AVPR1A—endocrine gland—breast cancer	0.00075	0.125	CbGeAlD
Desmopressin—PTGS1—nipple—breast cancer	0.000268	0.0445	CbGeAlD
Desmopressin—PTGS2—embryo—breast cancer	0.000211	0.0351	CbGeAlD
Desmopressin—PTGS1—epithelium—breast cancer	0.00018	0.03	CbGeAlD
Desmopressin—PTGS2—epithelium—breast cancer	0.000172	0.0287	CbGeAlD
Desmopressin—PTGS1—skin of body—breast cancer	0.000171	0.0285	CbGeAlD
Desmopressin—PTGS2—skin of body—breast cancer	0.000164	0.0273	CbGeAlD
Desmopressin—PTGS1—endometrium—breast cancer	0.000162	0.0269	CbGeAlD
Desmopressin—PTGS2—endometrium—breast cancer	0.000154	0.0257	CbGeAlD
Desmopressin—PTGS1—uterus—breast cancer	0.000149	0.0248	CbGeAlD
Desmopressin—PTGS1—pituitary gland—breast cancer	0.000146	0.0243	CbGeAlD
Desmopressin—PTGS1—adipose tissue—breast cancer	0.000146	0.0242	CbGeAlD
Desmopressin—PTGS2—uterus—breast cancer	0.000142	0.0237	CbGeAlD
Desmopressin—PTGS2—pituitary gland—breast cancer	0.00014	0.0233	CbGeAlD
Desmopressin—PTGS2—adipose tissue—breast cancer	0.000139	0.0232	CbGeAlD
Desmopressin—PTGS1—female reproductive system—breast cancer	0.000134	0.0223	CbGeAlD
Desmopressin—PTGS1—adrenal gland—breast cancer	0.000131	0.0217	CbGeAlD
Desmopressin—PTGS2—female reproductive system—breast cancer	0.000128	0.0213	CbGeAlD
Desmopressin—PTGS2—adrenal gland—breast cancer	0.000125	0.0208	CbGeAlD
Desmopressin—PTGS1—female gonad—breast cancer	0.000122	0.0203	CbGeAlD
Desmopressin—PTGS2—bone marrow—breast cancer	0.000121	0.0201	CbGeAlD
Desmopressin—PTGS2—female gonad—breast cancer	0.000116	0.0194	CbGeAlD
Desmopressin—PTGS1—endocrine gland—breast cancer	0.000113	0.0188	CbGeAlD
Desmopressin—PTGS2—endocrine gland—breast cancer	0.000108	0.018	CbGeAlD
Desmopressin—PTGS1—lymph node—breast cancer	7.83e-05	0.013	CbGeAlD
Desmopressin—PTGS2—lymph node—breast cancer	7.49e-05	0.0125	CbGeAlD
Desmopressin—Paraesthesia—Docetaxel—breast cancer	4.09e-05	0.000255	CcSEcCtD
Desmopressin—Vomiting—Gemcitabine—breast cancer	4.08e-05	0.000254	CcSEcCtD
Desmopressin—Dyspnoea—Docetaxel—breast cancer	4.06e-05	0.000253	CcSEcCtD
Desmopressin—Somnolence—Docetaxel—breast cancer	4.04e-05	0.000252	CcSEcCtD
Desmopressin—Mental disorder—Methotrexate—breast cancer	4.04e-05	0.000252	CcSEcCtD
Desmopressin—Rash—Gemcitabine—breast cancer	4.04e-05	0.000252	CcSEcCtD
Desmopressin—Dermatitis—Gemcitabine—breast cancer	4.04e-05	0.000252	CcSEcCtD
Desmopressin—Eye disorder—Epirubicin—breast cancer	4.04e-05	0.000252	CcSEcCtD
Desmopressin—Erythema—Methotrexate—breast cancer	4.02e-05	0.000251	CcSEcCtD
Desmopressin—Malnutrition—Methotrexate—breast cancer	4.02e-05	0.000251	CcSEcCtD
Desmopressin—Headache—Gemcitabine—breast cancer	4.02e-05	0.00025	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Capecitabine—breast cancer	4.01e-05	0.00025	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—breast cancer	4.01e-05	0.00025	CcSEcCtD
Desmopressin—Flushing—Epirubicin—breast cancer	4.01e-05	0.00025	CcSEcCtD
Desmopressin—Vomiting—Fluorouracil—breast cancer	4.01e-05	0.00025	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—breast cancer	4.01e-05	0.00025	CcSEcCtD
Desmopressin—Dyspepsia—Docetaxel—breast cancer	4e-05	0.00025	CcSEcCtD
Desmopressin—Insomnia—Capecitabine—breast cancer	3.98e-05	0.000248	CcSEcCtD
Desmopressin—Rash—Fluorouracil—breast cancer	3.97e-05	0.000248	CcSEcCtD
Desmopressin—Dermatitis—Fluorouracil—breast cancer	3.97e-05	0.000248	CcSEcCtD
Desmopressin—Paraesthesia—Capecitabine—breast cancer	3.96e-05	0.000247	CcSEcCtD
Desmopressin—Decreased appetite—Docetaxel—breast cancer	3.96e-05	0.000247	CcSEcCtD
Desmopressin—Hypersensitivity—Paclitaxel—breast cancer	3.95e-05	0.000247	CcSEcCtD
Desmopressin—Headache—Fluorouracil—breast cancer	3.95e-05	0.000246	CcSEcCtD
Desmopressin—Urinary tract disorder—Doxorubicin—breast cancer	3.95e-05	0.000246	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—breast cancer	3.94e-05	0.000246	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Docetaxel—breast cancer	3.93e-05	0.000245	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—breast cancer	3.93e-05	0.000245	CcSEcCtD
Desmopressin—Dyspnoea—Capecitabine—breast cancer	3.93e-05	0.000245	CcSEcCtD
Desmopressin—Fatigue—Docetaxel—breast cancer	3.92e-05	0.000245	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—breast cancer	3.92e-05	0.000244	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—breast cancer	3.92e-05	0.000244	CcSEcCtD
Desmopressin—Nausea—Mitoxantrone—breast cancer	3.91e-05	0.000244	CcSEcCtD
Desmopressin—Nausea—Irinotecan—breast cancer	3.91e-05	0.000244	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—breast cancer	3.9e-05	0.000243	CcSEcCtD
Desmopressin—Mediastinal disorder—Epirubicin—breast cancer	3.89e-05	0.000243	CcSEcCtD
Desmopressin—Pain—Docetaxel—breast cancer	3.89e-05	0.000243	CcSEcCtD
Desmopressin—Constipation—Docetaxel—breast cancer	3.89e-05	0.000243	CcSEcCtD
Desmopressin—Dyspepsia—Capecitabine—breast cancer	3.88e-05	0.000242	CcSEcCtD
Desmopressin—Chills—Epirubicin—breast cancer	3.88e-05	0.000242	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—breast cancer	3.85e-05	0.00024	CcSEcCtD
Desmopressin—Asthenia—Paclitaxel—breast cancer	3.85e-05	0.00024	CcSEcCtD
Desmopressin—Decreased appetite—Capecitabine—breast cancer	3.83e-05	0.000239	CcSEcCtD
Desmopressin—Nausea—Gemcitabine—breast cancer	3.81e-05	0.000237	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Capecitabine—breast cancer	3.8e-05	0.000237	CcSEcCtD
Desmopressin—Fatigue—Capecitabine—breast cancer	3.8e-05	0.000237	CcSEcCtD
Desmopressin—Pruritus—Paclitaxel—breast cancer	3.8e-05	0.000237	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—breast cancer	3.78e-05	0.000236	CcSEcCtD
Desmopressin—Pain—Capecitabine—breast cancer	3.77e-05	0.000235	CcSEcCtD
Desmopressin—Constipation—Capecitabine—breast cancer	3.77e-05	0.000235	CcSEcCtD
Desmopressin—Erythema—Epirubicin—breast cancer	3.76e-05	0.000234	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—breast cancer	3.76e-05	0.000234	CcSEcCtD
Desmopressin—Feeling abnormal—Docetaxel—breast cancer	3.75e-05	0.000234	CcSEcCtD
Desmopressin—Nausea—Fluorouracil—breast cancer	3.74e-05	0.000233	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—breast cancer	3.73e-05	0.000233	CcSEcCtD
Desmopressin—Ill-defined disorder—Methotrexate—breast cancer	3.73e-05	0.000232	CcSEcCtD
Desmopressin—Gastrointestinal pain—Docetaxel—breast cancer	3.72e-05	0.000232	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—breast cancer	3.71e-05	0.000231	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—breast cancer	3.71e-05	0.000231	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—breast cancer	3.71e-05	0.000231	CcSEcCtD
Desmopressin—Tension—Epirubicin—breast cancer	3.69e-05	0.00023	CcSEcCtD
Desmopressin—Diarrhoea—Paclitaxel—breast cancer	3.67e-05	0.000229	CcSEcCtD
Desmopressin—Nervousness—Epirubicin—breast cancer	3.65e-05	0.000228	CcSEcCtD
Desmopressin—Feeling abnormal—Capecitabine—breast cancer	3.63e-05	0.000226	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—breast cancer	3.63e-05	0.000226	CcSEcCtD
Desmopressin—Malaise—Methotrexate—breast cancer	3.62e-05	0.000226	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—breast cancer	3.62e-05	0.000225	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—breast cancer	3.61e-05	0.000225	CcSEcCtD
Desmopressin—Vertigo—Methotrexate—breast cancer	3.61e-05	0.000225	CcSEcCtD
Desmopressin—Gastrointestinal pain—Capecitabine—breast cancer	3.6e-05	0.000225	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—breast cancer	3.6e-05	0.000225	CcSEcCtD
Desmopressin—Abdominal pain—Docetaxel—breast cancer	3.6e-05	0.000224	CcSEcCtD
Desmopressin—Body temperature increased—Docetaxel—breast cancer	3.6e-05	0.000224	CcSEcCtD
Desmopressin—Chills—Doxorubicin—breast cancer	3.59e-05	0.000224	CcSEcCtD
Desmopressin—Dizziness—Paclitaxel—breast cancer	3.55e-05	0.000221	CcSEcCtD
Desmopressin—Cough—Methotrexate—breast cancer	3.51e-05	0.000219	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—breast cancer	3.5e-05	0.000218	CcSEcCtD
Desmopressin—Urticaria—Capecitabine—breast cancer	3.5e-05	0.000218	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—breast cancer	3.49e-05	0.000218	CcSEcCtD
Desmopressin—Abdominal pain—Capecitabine—breast cancer	3.48e-05	0.000217	CcSEcCtD
Desmopressin—Body temperature increased—Capecitabine—breast cancer	3.48e-05	0.000217	CcSEcCtD
Desmopressin—Convulsion—Methotrexate—breast cancer	3.48e-05	0.000217	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—breast cancer	3.48e-05	0.000217	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—breast cancer	3.48e-05	0.000217	CcSEcCtD
Desmopressin—Agitation—Epirubicin—breast cancer	3.46e-05	0.000215	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—breast cancer	3.43e-05	0.000214	CcSEcCtD
Desmopressin—Chest pain—Methotrexate—breast cancer	3.42e-05	0.000213	CcSEcCtD
Desmopressin—Myalgia—Methotrexate—breast cancer	3.42e-05	0.000213	CcSEcCtD
Desmopressin—Tension—Doxorubicin—breast cancer	3.41e-05	0.000213	CcSEcCtD
Desmopressin—Vomiting—Paclitaxel—breast cancer	3.41e-05	0.000213	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.4e-05	0.000212	CcSEcCtD
Desmopressin—Malaise—Epirubicin—breast cancer	3.39e-05	0.000211	CcSEcCtD
Desmopressin—Rash—Paclitaxel—breast cancer	3.38e-05	0.000211	CcSEcCtD
Desmopressin—Dermatitis—Paclitaxel—breast cancer	3.38e-05	0.000211	CcSEcCtD
Desmopressin—Discomfort—Methotrexate—breast cancer	3.38e-05	0.000211	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—breast cancer	3.38e-05	0.000211	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—breast cancer	3.38e-05	0.000211	CcSEcCtD
Desmopressin—Syncope—Epirubicin—breast cancer	3.37e-05	0.00021	CcSEcCtD
Desmopressin—Headache—Paclitaxel—breast cancer	3.36e-05	0.00021	CcSEcCtD
Desmopressin—Hypersensitivity—Docetaxel—breast cancer	3.35e-05	0.000209	CcSEcCtD
Desmopressin—Muscle spasms—Doxorubicin—breast cancer	3.34e-05	0.000209	CcSEcCtD
Desmopressin—Palpitations—Epirubicin—breast cancer	3.32e-05	0.000207	CcSEcCtD
Desmopressin—Confusional state—Methotrexate—breast cancer	3.31e-05	0.000206	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—breast cancer	3.3e-05	0.000206	CcSEcCtD
Desmopressin—Cough—Epirubicin—breast cancer	3.28e-05	0.000205	CcSEcCtD
Desmopressin—Anaphylactic shock—Methotrexate—breast cancer	3.28e-05	0.000204	CcSEcCtD
Desmopressin—Asthenia—Docetaxel—breast cancer	3.26e-05	0.000204	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—breast cancer	3.26e-05	0.000203	CcSEcCtD
Desmopressin—Infection—Methotrexate—breast cancer	3.26e-05	0.000203	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—breast cancer	3.25e-05	0.000202	CcSEcCtD
Desmopressin—Hypersensitivity—Capecitabine—breast cancer	3.25e-05	0.000202	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—breast cancer	3.23e-05	0.000201	CcSEcCtD
Desmopressin—Pruritus—Docetaxel—breast cancer	3.22e-05	0.000201	CcSEcCtD
Desmopressin—Nervous system disorder—Methotrexate—breast cancer	3.22e-05	0.000201	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—breast cancer	3.2e-05	0.0002	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—breast cancer	3.2e-05	0.0002	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—breast cancer	3.2e-05	0.000199	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—breast cancer	3.19e-05	0.000199	CcSEcCtD
Desmopressin—Nausea—Paclitaxel—breast cancer	3.19e-05	0.000199	CcSEcCtD
Desmopressin—Skin disorder—Methotrexate—breast cancer	3.19e-05	0.000199	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.18e-05	0.000198	CcSEcCtD
Desmopressin—Hyperhidrosis—Methotrexate—breast cancer	3.17e-05	0.000198	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—breast cancer	3.16e-05	0.000197	CcSEcCtD
Desmopressin—Asthenia—Capecitabine—breast cancer	3.16e-05	0.000197	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—breast cancer	3.14e-05	0.000196	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—breast cancer	3.13e-05	0.000195	CcSEcCtD
Desmopressin—Anorexia—Methotrexate—breast cancer	3.13e-05	0.000195	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—breast cancer	3.12e-05	0.000195	CcSEcCtD
Desmopressin—Pruritus—Capecitabine—breast cancer	3.12e-05	0.000194	CcSEcCtD
Desmopressin—Diarrhoea—Docetaxel—breast cancer	3.11e-05	0.000194	CcSEcCtD
Desmopressin—Confusional state—Epirubicin—breast cancer	3.09e-05	0.000193	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—breast cancer	3.07e-05	0.000192	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—breast cancer	3.07e-05	0.000191	CcSEcCtD
Desmopressin—Oedema—Epirubicin—breast cancer	3.07e-05	0.000191	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—breast cancer	3.06e-05	0.000191	CcSEcCtD
Desmopressin—Infection—Epirubicin—breast cancer	3.05e-05	0.00019	CcSEcCtD
Desmopressin—Cough—Doxorubicin—breast cancer	3.04e-05	0.000189	CcSEcCtD
Desmopressin—Shock—Epirubicin—breast cancer	3.02e-05	0.000188	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—breast cancer	3.01e-05	0.000188	CcSEcCtD
Desmopressin—Diarrhoea—Capecitabine—breast cancer	3.01e-05	0.000188	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—breast cancer	3.01e-05	0.000188	CcSEcCtD
Desmopressin—Dizziness—Docetaxel—breast cancer	3.01e-05	0.000188	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—breast cancer	3e-05	0.000187	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—breast cancer	3e-05	0.000187	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Methotrexate—breast cancer	2.99e-05	0.000186	CcSEcCtD
Desmopressin—Skin disorder—Epirubicin—breast cancer	2.98e-05	0.000186	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—breast cancer	2.97e-05	0.000185	CcSEcCtD
Desmopressin—Insomnia—Methotrexate—breast cancer	2.97e-05	0.000185	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—breast cancer	2.96e-05	0.000185	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—breast cancer	2.96e-05	0.000185	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—breast cancer	2.95e-05	0.000184	CcSEcCtD
Desmopressin—Paraesthesia—Methotrexate—breast cancer	2.94e-05	0.000184	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.94e-05	0.000183	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—breast cancer	2.93e-05	0.000182	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—breast cancer	2.93e-05	0.000182	CcSEcCtD
Desmopressin—Dyspnoea—Methotrexate—breast cancer	2.92e-05	0.000182	CcSEcCtD
Desmopressin—Somnolence—Methotrexate—breast cancer	2.92e-05	0.000182	CcSEcCtD
Desmopressin—Dizziness—Capecitabine—breast cancer	2.91e-05	0.000182	CcSEcCtD
Desmopressin—Vomiting—Docetaxel—breast cancer	2.89e-05	0.00018	CcSEcCtD
Desmopressin—Dyspepsia—Methotrexate—breast cancer	2.89e-05	0.00018	CcSEcCtD
Desmopressin—Rash—Docetaxel—breast cancer	2.87e-05	0.000179	CcSEcCtD
Desmopressin—Dermatitis—Docetaxel—breast cancer	2.87e-05	0.000179	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—breast cancer	2.86e-05	0.000179	CcSEcCtD
Desmopressin—Decreased appetite—Methotrexate—breast cancer	2.85e-05	0.000178	CcSEcCtD
Desmopressin—Headache—Docetaxel—breast cancer	2.85e-05	0.000178	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—breast cancer	2.84e-05	0.000177	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—breast cancer	2.84e-05	0.000177	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Methotrexate—breast cancer	2.83e-05	0.000177	CcSEcCtD
Desmopressin—Fatigue—Methotrexate—breast cancer	2.83e-05	0.000176	CcSEcCtD
Desmopressin—Infection—Doxorubicin—breast cancer	2.82e-05	0.000176	CcSEcCtD
Desmopressin—Pain—Methotrexate—breast cancer	2.8e-05	0.000175	CcSEcCtD
Desmopressin—Vomiting—Capecitabine—breast cancer	2.8e-05	0.000175	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.8e-05	0.000174	CcSEcCtD
Desmopressin—Shock—Doxorubicin—breast cancer	2.79e-05	0.000174	CcSEcCtD
Desmopressin—Nervous system disorder—Doxorubicin—breast cancer	2.78e-05	0.000174	CcSEcCtD
Desmopressin—Rash—Capecitabine—breast cancer	2.78e-05	0.000173	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—breast cancer	2.78e-05	0.000173	CcSEcCtD
Desmopressin—Dermatitis—Capecitabine—breast cancer	2.77e-05	0.000173	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—breast cancer	2.77e-05	0.000173	CcSEcCtD
Desmopressin—Headache—Capecitabine—breast cancer	2.76e-05	0.000172	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—breast cancer	2.76e-05	0.000172	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—breast cancer	2.76e-05	0.000172	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—breast cancer	2.74e-05	0.000171	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—breast cancer	2.74e-05	0.000171	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—breast cancer	2.73e-05	0.00017	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—breast cancer	2.71e-05	0.000169	CcSEcCtD
Desmopressin—Nausea—Docetaxel—breast cancer	2.7e-05	0.000169	CcSEcCtD
Desmopressin—Feeling abnormal—Methotrexate—breast cancer	2.7e-05	0.000169	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—breast cancer	2.7e-05	0.000168	CcSEcCtD
Desmopressin—Gastrointestinal pain—Methotrexate—breast cancer	2.68e-05	0.000167	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—breast cancer	2.67e-05	0.000166	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Epirubicin—breast cancer	2.65e-05	0.000165	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—breast cancer	2.65e-05	0.000165	CcSEcCtD
Desmopressin—Pain—Epirubicin—breast cancer	2.62e-05	0.000164	CcSEcCtD
Desmopressin—Constipation—Epirubicin—breast cancer	2.62e-05	0.000164	CcSEcCtD
Desmopressin—Nausea—Capecitabine—breast cancer	2.62e-05	0.000163	CcSEcCtD
Desmopressin—Urticaria—Methotrexate—breast cancer	2.61e-05	0.000162	CcSEcCtD
Desmopressin—Abdominal pain—Methotrexate—breast cancer	2.59e-05	0.000162	CcSEcCtD
Desmopressin—Body temperature increased—Methotrexate—breast cancer	2.59e-05	0.000162	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.59e-05	0.000161	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—breast cancer	2.57e-05	0.00016	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—breast cancer	2.55e-05	0.000159	CcSEcCtD
Desmopressin—Dyspnoea—Doxorubicin—breast cancer	2.53e-05	0.000158	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—breast cancer	2.53e-05	0.000158	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—breast cancer	2.52e-05	0.000157	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—breast cancer	2.51e-05	0.000156	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—breast cancer	2.5e-05	0.000156	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—breast cancer	2.47e-05	0.000154	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—breast cancer	2.45e-05	0.000153	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—breast cancer	2.45e-05	0.000153	CcSEcCtD
Desmopressin—Urticaria—Epirubicin—breast cancer	2.44e-05	0.000152	CcSEcCtD
Desmopressin—Pain—Doxorubicin—breast cancer	2.43e-05	0.000151	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—breast cancer	2.43e-05	0.000151	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—breast cancer	2.43e-05	0.000151	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—breast cancer	2.43e-05	0.000151	CcSEcCtD
Desmopressin—Hypersensitivity—Methotrexate—breast cancer	2.42e-05	0.000151	CcSEcCtD
Desmopressin—Asthenia—Methotrexate—breast cancer	2.35e-05	0.000147	CcSEcCtD
Desmopressin—Feeling abnormal—Doxorubicin—breast cancer	2.34e-05	0.000146	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—breast cancer	2.32e-05	0.000145	CcSEcCtD
Desmopressin—Pruritus—Methotrexate—breast cancer	2.32e-05	0.000145	CcSEcCtD
Desmopressin—Hypersensitivity—Epirubicin—breast cancer	2.26e-05	0.000141	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—breast cancer	2.26e-05	0.000141	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—breast cancer	2.24e-05	0.00014	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—breast cancer	2.24e-05	0.00014	CcSEcCtD
Desmopressin—Diarrhoea—Methotrexate—breast cancer	2.24e-05	0.00014	CcSEcCtD
Desmopressin—Asthenia—Epirubicin—breast cancer	2.2e-05	0.000137	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—breast cancer	2.17e-05	0.000135	CcSEcCtD
Desmopressin—Dizziness—Methotrexate—breast cancer	2.17e-05	0.000135	CcSEcCtD
Desmopressin—Diarrhoea—Epirubicin—breast cancer	2.1e-05	0.000131	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—breast cancer	2.09e-05	0.00013	CcSEcCtD
Desmopressin—Vomiting—Methotrexate—breast cancer	2.08e-05	0.00013	CcSEcCtD
Desmopressin—Rash—Methotrexate—breast cancer	2.07e-05	0.000129	CcSEcCtD
Desmopressin—Dermatitis—Methotrexate—breast cancer	2.07e-05	0.000129	CcSEcCtD
Desmopressin—Headache—Methotrexate—breast cancer	2.05e-05	0.000128	CcSEcCtD
Desmopressin—Asthenia—Doxorubicin—breast cancer	2.04e-05	0.000127	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—breast cancer	2.03e-05	0.000127	CcSEcCtD
Desmopressin—Pruritus—Doxorubicin—breast cancer	2.01e-05	0.000125	CcSEcCtD
Desmopressin—Vomiting—Epirubicin—breast cancer	1.95e-05	0.000122	CcSEcCtD
Desmopressin—Nausea—Methotrexate—breast cancer	1.95e-05	0.000121	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—breast cancer	1.94e-05	0.000121	CcSEcCtD
Desmopressin—Rash—Epirubicin—breast cancer	1.93e-05	0.000121	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—breast cancer	1.93e-05	0.000121	CcSEcCtD
Desmopressin—Headache—Epirubicin—breast cancer	1.92e-05	0.00012	CcSEcCtD
Desmopressin—Dizziness—Doxorubicin—breast cancer	1.88e-05	0.000117	CcSEcCtD
Desmopressin—Nausea—Epirubicin—breast cancer	1.82e-05	0.000114	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—breast cancer	1.81e-05	0.000113	CcSEcCtD
Desmopressin—Rash—Doxorubicin—breast cancer	1.79e-05	0.000112	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—breast cancer	1.79e-05	0.000112	CcSEcCtD
Desmopressin—Headache—Doxorubicin—breast cancer	1.78e-05	0.000111	CcSEcCtD
Desmopressin—Nausea—Doxorubicin—breast cancer	1.69e-05	0.000105	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—MAPK3—breast cancer	9.24e-06	9.9e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP17A1—breast cancer	9.11e-06	9.76e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.07e-06	9.72e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO1—breast cancer	9.02e-06	9.66e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MYC—breast cancer	8.99e-06	9.63e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.98e-06	9.62e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TGFB1—breast cancer	8.97e-06	9.6e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PIK3CA—breast cancer	8.95e-06	9.59e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MDM2—breast cancer	8.92e-06	9.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HSPA1B—breast cancer	8.92e-06	9.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.91e-06	9.54e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PIK3CA—breast cancer	8.89e-06	9.52e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RAF1—breast cancer	8.89e-06	9.52e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.87e-06	9.5e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MDM2—breast cancer	8.85e-06	9.48e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RELA—breast cancer	8.85e-06	9.48e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP2D6—breast cancer	8.84e-06	9.47e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RAF1—breast cancer	8.82e-06	9.45e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ERBB2—breast cancer	8.79e-06	9.42e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EGFR—breast cancer	8.79e-06	9.42e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RELA—breast cancer	8.78e-06	9.41e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.78e-06	9.4e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ERBB2—breast cancer	8.73e-06	9.35e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOA2—breast cancer	8.68e-06	9.3e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MTOR—breast cancer	8.68e-06	9.29e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CB—breast cancer	8.68e-06	9.29e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MED12—breast cancer	8.64e-06	9.25e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—DPYD—breast cancer	8.64e-06	9.25e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MTOR—breast cancer	8.61e-06	9.23e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CB—breast cancer	8.61e-06	9.23e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO1—breast cancer	8.55e-06	9.15e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALDOA—breast cancer	8.5e-06	9.11e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—FASN—breast cancer	8.42e-06	9.02e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—BCHE—breast cancer	8.38e-06	8.98e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CXCL8—breast cancer	8.34e-06	8.93e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—breast cancer	8.31e-06	8.9e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—breast cancer	8.28e-06	8.87e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC5A5—breast cancer	8.28e-06	8.87e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CXCL8—breast cancer	8.28e-06	8.87e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA3—breast cancer	8.26e-06	8.84e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—breast cancer	8.22e-06	8.81e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC2A2—breast cancer	8.2e-06	8.78e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1B—breast cancer	8.14e-06	8.72e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.11e-06	8.69e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1B—breast cancer	8.08e-06	8.66e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF3—breast cancer	8.08e-06	8.66e-05	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—AKT1—breast cancer	8.05e-06	8.63e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTR—breast cancer	8.03e-06	8.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CPT1A—breast cancer	8.03e-06	8.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCG2—breast cancer	8.03e-06	8.6e-05	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—AKT1—breast cancer	8e-06	8.57e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NQO1—breast cancer	8e-06	8.57e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC2A1—breast cancer	8e-06	8.57e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CASP3—breast cancer	7.98e-06	8.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—JAG1—breast cancer	7.98e-06	8.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FASN—breast cancer	7.98e-06	8.55e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL2—breast cancer	7.97e-06	8.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PARP1—breast cancer	7.95e-06	8.51e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL6—breast cancer	7.93e-06	8.49e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CASP3—breast cancer	7.92e-06	8.49e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL2—breast cancer	7.91e-06	8.47e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HPGDS—breast cancer	7.88e-06	8.44e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL6—breast cancer	7.87e-06	8.43e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CALCA—breast cancer	7.85e-06	8.41e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.83e-06	8.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HBA1—breast cancer	7.83e-06	8.38e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP3A4—breast cancer	7.8e-06	8.35e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCND1—breast cancer	7.77e-06	8.32e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.76e-06	8.31e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RPS6—breast cancer	7.76e-06	8.31e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JUN—breast cancer	7.75e-06	8.3e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCND1—breast cancer	7.71e-06	8.26e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JUN—breast cancer	7.7e-06	8.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF4—breast cancer	7.7e-06	8.24e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CTNNB1—breast cancer	7.69e-06	8.24e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP1B1—breast cancer	7.67e-06	8.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CXCR4—breast cancer	7.67e-06	8.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ACHE—breast cancer	7.64e-06	8.18e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTT1—breast cancer	7.64e-06	8.18e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CTNNB1—breast cancer	7.64e-06	8.18e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PIK3CA—breast cancer	7.63e-06	8.17e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SLC2A1—breast cancer	7.58e-06	8.12e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MMP9—breast cancer	7.54e-06	8.08e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HSP90AA1—breast cancer	7.52e-06	8.05e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1A—breast cancer	7.51e-06	8.05e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTEN—breast cancer	7.5e-06	8.03e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MMP9—breast cancer	7.49e-06	8.02e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1A—breast cancer	7.46e-06	7.99e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTEN—breast cancer	7.44e-06	7.97e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.41e-06	7.94e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TCF7L2—breast cancer	7.39e-06	7.92e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—breast cancer	7.38e-06	7.91e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MAPK8—breast cancer	7.33e-06	7.86e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—AKT1—breast cancer	7.31e-06	7.83e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOA1—breast cancer	7.31e-06	7.83e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MAPK8—breast cancer	7.28e-06	7.8e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—AKT1—breast cancer	7.26e-06	7.78e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP17A1—breast cancer	7.23e-06	7.74e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—STK11—breast cancer	7.21e-06	7.72e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP19A1—breast cancer	7.21e-06	7.72e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO1—breast cancer	7.16e-06	7.67e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTGS1—breast cancer	7.16e-06	7.67e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.13e-06	7.64e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HSP90AA1—breast cancer	7.13e-06	7.63e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—breast cancer	7.06e-06	7.56e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.04e-06	7.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2D6—breast cancer	7.02e-06	7.52e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SRC—breast cancer	6.95e-06	7.45e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRL—breast cancer	6.93e-06	7.43e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SRC—breast cancer	6.9e-06	7.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA2—breast cancer	6.89e-06	7.38e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ADAM10—breast cancer	6.83e-06	7.32e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—VEGFA—breast cancer	6.77e-06	7.25e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.77e-06	7.25e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL6—breast cancer	6.76e-06	7.24e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—VEGFA—breast cancer	6.72e-06	7.2e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—STAT3—breast cancer	6.71e-06	7.18e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—COMT—breast cancer	6.7e-06	7.18e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—FASN—breast cancer	6.68e-06	7.16e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTP1—breast cancer	6.67e-06	7.14e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—STAT3—breast cancer	6.66e-06	7.13e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—BCHE—breast cancer	6.65e-06	7.13e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF10—breast cancer	6.65e-06	7.12e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HMOX1—breast cancer	6.58e-06	7.05e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC5A5—breast cancer	6.57e-06	7.04e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ITPR1—breast cancer	6.56e-06	7.03e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PDGFA—breast cancer	6.41e-06	6.87e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MAPK3—breast cancer	6.41e-06	6.86e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MAPK3—breast cancer	6.36e-06	6.81e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC2A1—breast cancer	6.35e-06	6.8e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NQO1—breast cancer	6.35e-06	6.8e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFBR2—breast cancer	6.32e-06	6.77e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ABCB1—breast cancer	6.31e-06	6.76e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKT1—breast cancer	6.23e-06	6.68e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MYC—breast cancer	6.23e-06	6.67e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ITPR1—breast cancer	6.22e-06	6.66e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.22e-06	6.66e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TGFB1—breast cancer	6.22e-06	6.66e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TYMS—breast cancer	6.2e-06	6.64e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP3A4—breast cancer	6.19e-06	6.63e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MYC—breast cancer	6.19e-06	6.63e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT5A—breast cancer	6.18e-06	6.62e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB4—breast cancer	6.18e-06	6.62e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TGFB1—breast cancer	6.17e-06	6.61e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PLA2G4A—breast cancer	6.13e-06	6.56e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTM1—breast cancer	6.13e-06	6.56e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOR1—breast cancer	6.13e-06	6.56e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EGFR—breast cancer	6.09e-06	6.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP1B1—breast cancer	6.09e-06	6.52e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EGFR—breast cancer	6.05e-06	6.48e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SMAD4—breast cancer	5.98e-06	6.41e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HSP90AA1—breast cancer	5.97e-06	6.39e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GPX1—breast cancer	5.87e-06	6.29e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HES1—breast cancer	5.84e-06	6.26e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP1A1—breast cancer	5.81e-06	6.22e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NCOR1—breast cancer	5.81e-06	6.22e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA1—breast cancer	5.81e-06	6.22e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ERCC2—breast cancer	5.76e-06	6.17e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—breast cancer	5.76e-06	6.17e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF1—breast cancer	5.74e-06	6.15e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—STK11—breast cancer	5.72e-06	6.13e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP19A1—breast cancer	5.72e-06	6.13e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—breast cancer	5.72e-06	6.12e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRG1—breast cancer	5.7e-06	6.11e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—H2AFX—breast cancer	5.66e-06	6.06e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERCC2—breast cancer	5.46e-06	5.85e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—MTHFR—breast cancer	5.42e-06	5.8e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.37e-06	5.75e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB3—breast cancer	5.34e-06	5.72e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR2—breast cancer	5.33e-06	5.71e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—COMT—breast cancer	5.32e-06	5.7e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTP1—breast cancer	5.29e-06	5.67e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CA—breast cancer	5.29e-06	5.67e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CA—breast cancer	5.25e-06	5.62e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HMOX1—breast cancer	5.22e-06	5.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ITPR1—breast cancer	5.21e-06	5.58e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTHFR—breast cancer	5.13e-06	5.5e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TERT—breast cancer	5.12e-06	5.48e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—breast cancer	5.12e-06	5.48e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—breast cancer	5.08e-06	5.44e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ABCB1—breast cancer	5.01e-06	5.37e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CAV1—breast cancer	5e-06	5.35e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR1—breast cancer	4.97e-06	5.33e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TYMS—breast cancer	4.92e-06	5.27e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HIF1A—breast cancer	4.9e-06	5.24e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—breast cancer	4.89e-06	5.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOR1—breast cancer	4.87e-06	5.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PLA2G4A—breast cancer	4.87e-06	5.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTM1—breast cancer	4.87e-06	5.21e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—breast cancer	4.86e-06	5.2e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.77e-06	5.11e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CAV1—breast cancer	4.74e-06	5.07e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL6—breast cancer	4.68e-06	5.02e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GPX1—breast cancer	4.66e-06	4.99e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL6—breast cancer	4.65e-06	4.98e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP1A1—breast cancer	4.61e-06	4.94e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ERCC2—breast cancer	4.57e-06	4.9e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CG—breast cancer	4.55e-06	4.87e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOS2—breast cancer	4.45e-06	4.77e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOTCH1—breast cancer	4.41e-06	4.73e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKT1—breast cancer	4.32e-06	4.63e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—APC—breast cancer	4.31e-06	4.62e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KIT—breast cancer	4.31e-06	4.62e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTHFR—breast cancer	4.3e-06	4.61e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKT1—breast cancer	4.29e-06	4.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGF—breast cancer	4.26e-06	4.57e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BRAF—breast cancer	4.06e-06	4.34e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CD—breast cancer	4e-06	4.29e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CAV1—breast cancer	3.97e-06	4.25e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ALB—breast cancer	3.95e-06	4.23e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT2—breast cancer	3.95e-06	4.23e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CD—breast cancer	3.79e-06	4.06e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.79e-06	4.06e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NOS3—breast cancer	3.78e-06	4.05e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SERPINE1—breast cancer	3.75e-06	4.02e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CG—breast cancer	3.61e-06	3.87e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOS3—breast cancer	3.58e-06	3.84e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CB—breast cancer	3.49e-06	3.74e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—breast cancer	3.46e-06	3.7e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MDM2—breast cancer	3.4e-06	3.64e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RAF1—breast cancer	3.39e-06	3.63e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB2—breast cancer	3.35e-06	3.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTOR—breast cancer	3.31e-06	3.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CB—breast cancer	3.31e-06	3.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CD4—breast cancer	3.3e-06	3.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CD—breast cancer	3.18e-06	3.4e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ALB—breast cancer	3.14e-06	3.36e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1B—breast cancer	3.1e-06	3.32e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTEN—breast cancer	3.01e-06	3.23e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NOS3—breast cancer	3e-06	3.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CTNNB1—breast cancer	2.93e-06	3.14e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1A—breast cancer	2.86e-06	3.07e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTEN—breast cancer	2.86e-06	3.06e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CB—breast cancer	2.77e-06	2.97e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SRC—breast cancer	2.65e-06	2.84e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT3—breast cancer	2.55e-06	2.74e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MAPK3—breast cancer	2.44e-06	2.61e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTEN—breast cancer	2.39e-06	2.56e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MYC—breast cancer	2.37e-06	2.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFB1—breast cancer	2.37e-06	2.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGFR—breast cancer	2.32e-06	2.49e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—breast cancer	2.19e-06	2.35e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CA—breast cancer	2.13e-06	2.28e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CA—breast cancer	2.02e-06	2.16e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—breast cancer	1.86e-06	2e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IL6—breast cancer	1.78e-06	1.91e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKT1—breast cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CA—breast cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT1—breast cancer	1.65e-06	1.76e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKT1—breast cancer	1.38e-06	1.48e-05	CbGpPWpGaD
